4.2 Article

Smith-Magenis syndrome and Moyamoya disease in a patient with del(17)(p11.2p13.1)

期刊

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 143A, 期 9, 页码 999-1008

出版社

WILEY
DOI: 10.1002/ajmg.a.31689

关键词

Smith-Magenis syndrome; MLPA; array-CGH; 17p11.2 deletion; moyamoya; cerebrovascular abnormalities

资金

  1. NICHD NIH HHS [R01 HD38534] Funding Source: Medline

向作者/读者索取更多资源

Chromosomal rearrangements causing microdeletions and microduplications are a major cause of congenital malformation and mental retardation. Because they are not visible by routine chromosome analysis, high resolution whole-genome technologies are required for the detection and diagnosis of small chromosomal abnormalities. Recently, array-comparative genomic hybridization (aCGH) and multiplex ligation-dependent probe amplification (MLPA) have been useful tools for the identification and mapping of deletions and duplications at higher resolution and throughput. Smith-Magenis syndrome (SMS) isa multiple congenital anomalies/mental retardation syndrome caused by deletion or mutation of the retinoic acid induced 1 (RAI1) gene and is often associated with a chromosome 17p11.2 deletion. We report here on the clinical and molecular analysis of a 10-year-old girl with SMS and moyamoya disease (occlusion of the circle of Willis). We have employed a combination of aCGH, FISH, and MLPA to characterize an similar to 6.3 Mb deletion spanning chromosome region 17p11.2-p13.1 in this patient, with the proximal breakpoint within the RAI1 gene. Further, investigation of the genomic architecture at the breakpoint intervals of this large deletion documented the presence of palindromic repeat elements that could potentially form recombination substrates leading to unequal crossover. (C) 2007 Wiley-I.iss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据